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Abstract
Background: This study addresses the safety, feasibility, and interpretability of coronary
computed tomography angiography (CCTA) in excluding significant coronary artery disease
in end-stage renal disease patients on dialysis undergoing pre-renal transplant cardiac risk
evaluation.
Methods: Twenty nine patients (55.5 ± 10.2 years) undergoing cardiac risk assessment
prior to renal transplantation, underwent research CCTA with calcium scoring and formed
the study group. All CCTAs were performed using retrospective acquisition, with beta-blockade
provided one hour prior to scanning.
Results: No major complications occurred in this group up to 30 days after CCTA. Of the
total of 374 segments interpreted by both readers, only 36 (10%) were uninterpretable by both
readers. Of these, 31 (86%) were from distal segments or branches. On a segmental level, there
was 95% concordance between both readers for < 50% stenosis detection. Only three out of
28 (11%) CCTAs were deemed uninterpretable. Ten patients (36%) had zero calcium score,
despite being on dialysis with no evidence of obstructive coronary artery disease by CCTA.
Conclusions: CCTA is feasible and safe in end-stage renal disease dialysis patients with the
advent of 64-slice CCTA. Despite significant calcium burden, there was excellent inter-ob-
server agreement at segment level for the left main and all three proximal-mid coronary
arteries in excluding obstructive coronary artery disease (> 50% stenosis). (Cardiol J 2010;
17, 4: 349–361)
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Introduction
Cardiovascular disease is the leading cause of
mortality in end-stage renal disease (ESRD) pa-
tients on dialysis, accounting for 40–45% of all
deaths [1]. The annual all-cause mortality rate for
all US dialysis patients in 2002 was 210 per 1,000
patient years [2]. Therefore, renal transplantation
(RT) is the treatment of choice for patients with
ESRD and has been shown to improve survival.
Cardiac screening of RT candidates is recommended
in the hope of  preventing cardiovascular death after
transplantation [3]. Given a limited organ donor pool,
adequate cardiac risk stratification is crucial.
Conflicting evidence exists regarding the best
way to predict cardiac risk in ESRD patients prior
to RT [4, 5]. Although we and others have shown
that stress echocardiography (SE) and stress myo-
cardial perfusion imaging (SMPI) are widely used
in the initial risk stratification of RT candidates [6,
7], there are limitations with these techniques in
ESRD patients. False positive SMPI from underly-
ing co-morbidities such as hypertension and diabe-
tes and endothelial dysfunction can occur in ESRD
patients, who have a high prevalence of these con-
ditions [8–10].
Dobutamine stress echocardiography (DSE)
may be inconclusive or non-diagnostic due to the
inability to achieve ≥ 85% maximal predicted heart
rate which is a significant problem in this popula-
tion [6]. Finally, coronary angiography, still consi-
dered the ‘gold standard’, is invasive and may ex-
pose patients to unnecessary risk considering that
only a small fraction of non-diabetic ESRD patients
have significant obstructive coronary artery disease
(CAD) and very few revascularizations are per-
formed in the subgroup of ESRD patients who un-
dergo angiography [6, 11]. In a recent comprehen-
sive review of coronary risk assessment in ESRD
patients awaiting RT, we looked at all existing
diagnostic modalities, and their limitations, and out-
lined possible strategies for approaching the ESRD
population who represent a big challenge to the
diagnostic armamentarium [12].
Rapid technological advances and new clinical
applications in cardiovascular imaging technology
have made coronary computed tomography angio-
graphy (CCTA) more widely available and increas-
ingly popular. The value of CCTA lies mainly in its
negative predictive value or its ability to exclude
significant obstructive CAD [13]. ESRD patients on
dialysis have largely been excluded from CCTA tri-
als due to the high coronary artery calcium burden
which may interfere with CCTA evaluation, as well
as the high contrast volume load which raises safety
concerns in ESRD patients with residual renal func-
tion. Thus, the exact role, if any, of CCTA in ESRD
dialysis patients is unknown which forms the basis
of this pilot study focusing on the pre-RT population.
The main aims of this study were firstly to as-
sess the feasibility and interpretability of CCTA to
exclude major proximal-mid epicardial vessel CAD
which may affect revascularization decisions prior
to RT; secondly, to determine the immediate and
short term safety of CCTA procedure in ESRD
dialysis patients undergoing pre-RT risk stratifica-
tion; and thirdly to compare CCTA to dobutamine
echocardiography in a subset of patients undergo-
ing the latter for pre-transplant risk stratification.
Methods
Study population
Twenty-nine consecutive ESRD patients on
dialysis referred for RT evaluation at Henry Ford
Hospital were prospectively studied. All patients
signed a written informed consent and the study
was approved by the institutional review board at
Henry Ford Hospital. One patient could not com-
plete the CCTA due to IV infiltration and therefore
was excluded from analysis, resulting in a final sam-
ple size of 28 patients. All were required to under-
go a standard CCTA examination, as per the study
protocol. Cardiac CTA findings were blinded to the
referring physician as well as to the patient. Any
significant non-cardiac findings noted were commu-
nicated to the patient’s primary physician. Patients
underwent routine clinical risk assessment as per
our institution’s RT work-up protocol and 23 pa-
tients also underwent a DSE (n = 20) or single-
-photon emission computed tomography (SPECT)
(n = 3) examination as part of their risk stratifica-
tion. The clinical assessment and stress test results
were the only information used to make decisions
for RT candidacy.
Exclusion criteria included age < 18 years,
inability or refusal to sign consent, pregnancy, al-
lergy or hypersensitivity to iodine, atrial fibrillation
or significant ectopy precluding gating, ejection
fraction < 40% or fluid overload status, contraindi-
cations to beta-blockers, and inability to obtain IV
access. ESRD patients not on dialysis, or with rea-
sonable residual renal function despite dialysis as
determined by the nephrologist, were also exclud-
ed from the study to avoid any worsening of renal
function secondary to contrast exposure.
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Coronary computed tomography angiography
CCTA examinations were performed using
a Siemens or GE 64-slice computed tomography
scanner. In all patients, a non-contrast enhanced
scan was performed prior to the 64-slice computed
tomography angiography to assess the total coro-
nary artery calcium burden by Agatston method.
All patients were asked to continue their ex-
isting anti-hypertensive medications, particularly
beta-blockers prior to the test. The CCTA was per-
formed on non-dialysis days. In patients with a HR
≥ 60 bpm, 50–150 mg of metoprolol was given prior
to the CCTA if there was no contraindication to
beta-blocker use. In addition, 2.5 mg of isosorbide
dinitrate was used to facilitate coronary vasodilata-
tion during the examination. Retrospective gating
was employed with reconstructions performed at
65%, 70%, and 75% of the RR interval. The CCTA
reconstructions were evaluated by standard metho-
dology using maximum intensity projections fol-
lowed by multi-planar reformatted images. The con-
trast agent used was 80cc of Optiray or Isovue. The
patients were evaluated after the CCTA examina-
tion by a cardiology fellow or staff radiologist and
were discharged from the facility when deemed sta-
ble clinically 30–45 minutes after the CCTA. The
CCTAs were interpreted by two qualified CCTA
Level 3-equivalent physicians blinded to all patient
data. A third qualified reader settled any significant
discrepancies. An 18-segment coronary vessel tree
was used for grading. We used a six point scale for
interpretation of stenosis (0 = normal,  1 = 1–25%,
2 = 26–50%, 3 = 51–70%, 4 > 70%, 5 = 100%
stenosis). This grading was used for all segments
and for overall study quality. In addition, assess-
ment also included description of plaque as calci-
fied, non-calcified, or mixed plaque. Quality of the
study was rated as high, adequate, poor, or unin-
terpretable (based on motion and heart rate relat-
ed issues). Standardized reporting format for CCTA
coronary anatomy/plaque interpretation was used
in our institution, similar to published guidelines
[14], and was used by all readers.
Follow-up
Although not a primary aim of the study, in
order to ensure that the CCTA procedure did not
result in short term adverse consequences, the
28 patients were all followed up to identify any 30-day
events following the CCTA examination. These
30-day events included death, myocardial infarction,
congestive heart failure, and any reactions which
could be directly attributable to the CCTA proce-
dure. These events were mainly identified through
electronic chart review focusing on emergency
room visits, hospital admissions, and dialysis notes
in the 30 days following CCTA.
Statistical analysis
All two-group comparisons of numeric data
were performed using t-tests when the data is nor-
mally distributed, otherwise using the Wilcoxon
rank sum test. All two-group comparisons of cate-
gorical data were performed using the c2 test for
proportions when none of the expected cell counts
are less than five, otherwise using the Fisher ex-
act test. Segment independence has been assumed
when comparing the interpretable segments to the
uninterpretable segments. Spearman correlation
coefficients and corresponding p-values have been
used to evaluate the correlation between stenosis
level and calcium score. The Kappa statistic has
been used to measure the reader agreement of the
segment stenosis levels. P-values less than 0.05
have been considered statistically significant
throughout.
Results
A CCTA including calcium score estimation
was performed in 28 patients. Table 1 displays their
baseline demographics and characteristics. The
notable findings were a rather young population
(mean age of 55.2 ± 10.0 years) with a predomi-
nance of males (75%) and African American race
(89%). All had hypertension and 93% were on he-
modialysis. The etiologies of ESRD were hyperten-
sion in 39%, diabetes in 14% and a combination of
hypertension and diabetes in 25%. Primary renal
etiologies accounted for 22% of causes for ESRD.
The mean duration of dialysis was 3.1 ± 3.5 years
with an excellent average calcium-phosphorus pro-
duct of 45.4 ± 8.2. There were 18 patients (64.3%)
on beta-blockers and 16 patients (57.1%) on calcium
channel blockers. A dose of 50–150 mg of oral meto-
prolol was administered to 22 patients (78.5%) to
lower the heart rate, resulting in an average heart
rate at acquisition of 64.9 beats/min.
The various CCTA characteristics are dis-
played in Table 2. Three out of the 28 CCTAs were
considered uninterpretable and were excluded from
analysis. A total of 123 coronary arteries were ana-
lyzed in this study. Using an 18-segment model,
only 374 out of 504 (75%) coronary segments were
analyzed by both readers, due mainly to inability to
adequately visualize the most distal segments for
analysis. The overall mean calcium scores in the
CCTAs were 648.1 ± 1632.0. In addition, the ma-
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jority of the 25 interpretable CCTAs were consid-
ered adequate or high quality studies (61% for
Reader 1 and 64% for Reader 2). Table 3 shows the
comparison of variables for the 374 segments,
breaking them down into interpretable (277) and un-
interpretable (36) segments. Surprisingly, a higher
heart rate was the only significant predictor of in-
terpretability. Of the 36 uninterpretable segments,
86% were in the distal branch vessels of the coro-
nary arteries.
Figure 1 shows the distribution of overall cal-
cium scores across the range of stenosis reported.
As can be seen, there is a significant correlation
between higher calcium scores and more severe
stenosis, although the number of patients with se-
vere stenosis is very small. Figure 2 shows the dis-
tribution of the calcium scores in individual arteries
analyzed at varying levels of stenosis severity. De-
spite very high calcium scores, many patients (par-
ticularly noted in the left artery descending and left
circumflex distribution) had non-significant (< 50%)
stenosis, highlighting the fact that a high calcium
score does not automatically translate to a tight
stenosis in this high-risk patient subset. Figure 3
displays the distribution of stenosis in different ar-
teries. As illustrated, a majority of the stenosis in
all three major vessels as well as the left main were
less than 50%.
There was overall good correlation for adequa-
cy of interpretability of segments between Reader 1
and Reader 2. Of the 374 segments examined,
Table 1. Baseline characteristics.
Characteristics Total
Age (years) 55.2 ± 10.0
Gender:
Male (%) 75.0
Female (%) 25.0
African American (%) 89
History of hypertension (%) 100.0
History of diabetes mellitus (%) 50.0
Type of dialysis:
Hemodialysis (%) 92.9
Peritoneal dialysis (%) 7.1
Dialysis years 3.1 ± 3.5
Body mass index 31.3 ± 8.0
Calcium × phosphorous product 45.4 ± 8.2
Heart rate 76.3 ± 12.6
Heart rate acquisition 64.9 ± 5.4
Systolic blood pressure 137.0 ± 19.4
Diastolic blood pressure 77.1 ± 14.0
Prior beta-blocker usage (%) 64.3
Prior calcium channel blocker usage (%) 57.1
IV metoprolol dose used:
0 (%) 96.4
5 (%) 3.6
PO metoprolol dose used:
0 (%) 21.4
50 (%) 10.7
100 (%) 46.4
150 (%) 21.4
Table 2. Coronary computed tomography angiography characteristics.
Characteristics Reader 1 Reader 2 Reader 3
(28 patients)  (28 patients)  (two patients)
Overall calcium score 648.1 ± 1632.0 648.1 ± 1632.0
RCA calcium score 202.4 ± 621.6 202.4 ± 621.6
LM calcium score 26.3 ± 66.2 26.3 ± 66.2
LAD calcium score 285.1 ± 748.9 285.1 ± 748.9
LCX calcium score 134.2 ± 293.5 134.2 ± 293.5
Study quality:
Adequate–high 17/28 (61%) 18/28 (64%) 0/2 (0%)
Poor 11/28 (39%) 10/28 (36%) 2/2 (100%)
Overall study uninterpretable (fraction and %) 1/28 (3.6%) 3/28 (10.7%) 0/2 (0%)
LM stenosis uninterpretable (fraction and %) 1/28 (3.6%) 2/28 (7.1%) 0/2 (0%)
LAD stenosis uninterpretable (fraction and %) 0/28 (0.0%) 2/28 (7.1%) 0/2 (0%)
LCX stenosis uninterpretable (fraction and %) 2/28 (7.1%) 3/28 (10.7%) 0/2 (0%)
RCA stenosis uninterpretable (fraction and %) 3/28 (10.7%) 3/28 (10.7%) 0/2 (0%)
RCA — right coronary artery; LM — left main; LAD — left arterior descending; LCX — left circumflex
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Table 3. Factors influencing segment interpretability.
Variable Intrepretable by Uninterpretable by Comparison
both readers (n = 277)  both readers (n = 36)  (p)
Overall calcium score 611.0 ± 1697.8 648.3 ± 1354.8 0.784
Overall calcium score ≥ 400 46 (16.6%) 9 (25.0%) 0.213
Overall moderate/severe calcium 124 (44.8%) 15 (41.7%) 0.725
Overall poor signal to noise ratio 169 (61.0%) 27 (75.0%) 0.103
Overall moderate/severe motion 151 (54.5%) 19 (52.8%) 0.844
Body mass index 31.3 ± 7.2 30.9 ± 9.7 0.762
Heart rate 77.4 ± 12.3 71.6 ± 9.6 0.006
Calcium × phosphorous product 45.1 ± 8.4 43.7 ± 4.6 0.360
Years on dialysis 3.3 ± 3.6 3.1 ± 2.9 0.970
Figure 1. Individual calcium scores by stenosis levels.
277 (74%) were deemed interpretable by both read-
ers, whereas 36 (10%) were deemed uninterpret-
able by both readers (Table 4). Of the uninterpret-
able segments, most (86%) were located in distal
segments or branches. Furthermore, the inter-read-
er agreement at the segment level for identifying
less than 50% stenosis in 25 out of 28 patients was
excellent, with a 96% concordance (both readers
concordant for < 50% stenosis in 266 out of 277 se-
gments). The overall Kappa statistic at segment
level was fair at 0.46, which suggested a moderate
level of correlation.
Ten out of the 28 (36%) patients actually had
a total calcium score of 0. Six patients had a total
coronary calcium score of 1–100, six patients had
a total coronary calcium score of 101–400, and six
patients had a total coronary calcium score of > 400.
All ten of the patients with an overall coronary cal-
cium score of 0 had normal coronary arteries by
CCTA. Table 5 displays the relevant variables, com-
paring those with a calcium score of 0 to those with
a calcium score higher than zero. No significant
differences were noted between the two groups.
Twenty out of the 28 patients (71%) underwent
a DSE as part of pre-transplant assessment in addi-
tion to a CCTA as deemed necessary by their phy-
sician. Table 6 displays the stress testing charac-
teristics for the DSE studies that were performed.
Table 7 shows the correlation between the DSE
studies and CCTA in those 20 patients. Nine out of
the 20 (45%) DSE studies were considered incon-
clusive or sub-maximal, mainly due to an inability
to achieve ≥ 85% of the maximal predicted heart
rate. The remaining DSE studies were all considered
conclusive and negative for ischemia. In contrast,
only three out of the 28 (11%) CCTAs performed
were deemed uninterpretable. All nine patients with
a sub-maximal dobutamine echocardiogram had an
Figure 2. Distribution of calcium scores in individual
coronary arteries; RCA — right coronary artery; LAD —
left artery descending; LCX — left circumflex.
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interpretable CCTA and eight of them displayed
a stenosis of < 70% in the proximal-mid coronary
arteries. Figures 4A–D shows CCTA examples of
four study patients. Patients 4A and 4B had in-
conclusive stress tests, but had CCTAs showing
zero coronary calcium and no CAD. Patient 4C
had a submaximal stress test, elevated calcium
score, and no obstructive CAD. Finally, patient
4D had severe coronary calcification, no signifi-
cant proximal obstructive disease despite this
high calcium burden, and only mild-moderate dis-
tal right coronary artery disease by CCTA. A fol-
low-up coronary angiogram revealed non-obstruc-
tive CAD, demonstrating that even markedly
elevated calcium scores may not correlate with
severe stenosis.
Follow-up
Although not a primary end-point in the study,
a short 30-day follow-up period was obtained to
evaluate the immediate post-CCTA outcomes. No
serious adverse events were recorded. One patient
was hospitalized for gastrointestinal bleeding felt
to be secondary to oral anticoagulants. No signifi-
cant change in patient symptomatology or dialysis
frequency was noted, suggesting that CCTA had no
adverse impact in this period.
Discussion
This study shows that CCTA is a feasible and
safe modality in patients with pre-RT ESRD on
dialysis. There were no immediate or short term
Table 4. Segment stenosis interpretability by readers.
Reader 1 Reader 2
Interpretable Uninterpretable Total
Interpretable 277 (74%) 22 (6%) 299 (80%)
Uninterpretable 39 (10%) 36 (10%) 75 (20%)
Total 316 (84%) 58 (16%) 374
Figure 3. Distribution of stenosis by coronary artery; RCA — right coronary artery; LAD — left artery descending;
LCX — left circumflex.
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adverse reactions to pre-medications or radiocontrast
dye used as part of CCTA. Secondly, our study shows
that diagnostic images to exclude major vessel CAD,
which could impact patient management prior to RT,
was possible in the majority of the patients with cur-
rent 64-slice CCTA technology. Although our study
sample size is very small, thus precluding definitive
conclusions, our study shows that a certain subset
(10/28, 36%) ESRD dialysis patients actually have
a low to zero calcium burden, which by itself makes
major obstructive CAD very unlikely. If confirmed by
Table 5. Subgroup analysis based on calcium score (0 vs non-0).
Variable Calcium score non-zero Calcium score zero P
(n = 18)  (n = 10)
Age (years) 56.2±10.0 53.2±10.2 0.455
Female gender 2 (11.1%) 5 (50.0%) 0.063
Diabetes mellitus 10 (55.6%) 4 (40.0%) 0.430
Dialysis mode: 0.276
HD 15 (83.3%) 7 (70.0%)
PD 2 (11.1%) 0 (0.0%)
Both 1 (5.6%) 3 (30.0%)
Dialysis (years) 3.1 ± 3.9 3.2 ± 2.6 0.429
Prior TP 2 (11.1%) 1 (10.0%) 1.000
Phosphorous binder: 1.000
None 3 (16.7%) 1 (10.0%)
Non calcium 10 (55.6%) 6 (60.0%)
Calcium containing 4 (22.2%) 2 (20.0%)
Both 1 (5.6%) 1 (10.0%)
Average calcium 9.0±0.5 8.5±0.9 0.073
Average phosphorous 5.0±0.7 5.4±1.2 0.367
Average PTH 499.9±201.6 726.1±679.9 0.733
Average albumin 4.0±0.3 4.0±0.2 0.733
Calcium × phosphorous product 45.4±7.0 45.4±10.0 0.998
Ejection fraction (%) 55.1±7.9 57.2±5.1 0.447
Body mass index 32.8±8.9 28.8±5.5 0.209
HD — hemodialysis; PD — peritoneal dialysis; TP — transplantation
Table 6. Dobutamine stress test characteristics.
Characteristics Total
Dobutamine stress 20
echocardiography
Ejection fraction (%) 55.8 ± 7.0
Conclusive 11 (55%)
Submaximal 9 (45%)
Positive 0
Negative 11 (55%)
Table 7. Dobutamine stress echocardiography (DSE)/computed tomography angiography (CTA) correlation.
DSE results CTA results
£ 70% stenosis ≥ 70% stenosis Uninterpretable Total
Negative 10 (50%) 0 1 (5%) 11 (55%)
Inconclusive 8 (40%) 1 (5%) 0 9 (45%)
Total 18 (90%) 1 (5%) 1 (5%) 20
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larger studies, this makes CCTA a diagnostic option
in this subset where further testing could be avoided
if patients are asymptomatic during their pre-RT eval-
uation process.
The main modalities used for RT cardiovascu-
lar risk assessment include exercise electrocardio-
graphy (ECG) testing, myocardial perfusion imag-
ing, or echocardiography using exercise or dobu-
Figure 4. A. A 55 year-old patient on hemodialysis; submaximal dobutamine stress echocardiography requiring
additional testing with stress myocardial perfusion scan. His research coronary computed tomography angiography
(CCTA) is shown. As can be seen, there was no coronary calcium detected and no obstructive coronary artery
disease documented and the CCTA was of diagnostic quality.
Calcium score
Region Agatston Volume Density Threshold (1–30):
LM 0 0 Pixel Threshold: 3
RCA 0 0 Algorithm: Discrete
LAD 0 0
CX 0 0
PDA 0 0
Other 1 0 0
Other 2 0 0
Other 3 0 0
Total 0 0
Left anterior descending artery Left circumflex artery
Left circumflex/obtuse marginal branch
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Figure 4. B. A 57 year-old patient with diabetes on hemodialysis; equivocal stress echocardiography referred for
coronary angiography. Research CCTA shows zero calcium score and no significant coronary disease and interpreta-
ble scan.
Calcium score
Region Agatston Volume Density Threshold (1–30):
LM 0 0 Pixel Threshold: 3
RCA 0 0 Algorithm: Discrete
LAD 0 0
CX 0 0
PDA 0 0
Other 1 0 0
Other 2 0 0
Other 3 0 0
Total 0 0
Left anterior descending artery
Left circumflex artery Right coronary artery
tamine. While exercise ECG testing has been
shown to identify patients at increased surgical risk
in the non-ESRD population, there are few studies
examining this screening modality in patients with
renal failure, mainly due to the markedly reduced
exercise capacity of these patients and abnormal
baseline ECG. In a recent study of RT candidates,
exercise ECG only had a sensitivity of 32% for pre-
dicting coronary artery disease [11].
Debate still exists regarding the accuracy and
predictive value of DSE in the evaluation of ESRD
patients who are being considered for renal trans-
plant. The study by Herzog et al. [15] showed that
20% of RT candidates with a negative DSE expe-
rienced cardiac death, myocardial infarction, or co-
ronary revascularization. In support of non-invasive
risk stratification, studies from the authors’ insti-
tution showed very good negative predictive value,
with a negative SE and much worse outcomes for
those with positive SE regardless of extent of an-
giographic disease [6].
De Lima et al. [4] demonstrated that both DSE
and SPECT have very low sensitivities (< 60%) for
predicting obstructive CAD. In this study, only risk
stratification and coronary angiography (CA) were
able to reliably predict the probability of event-free
survival. However, there is no convincing evidence
that routine CA is needed in all RT candidates, as
only a minority of these diagnostic catheterizations
lead to any revascularization in the pre-RT ESRD
patient [6, 11].
CCTA is an excellent non-invasive tool for ex-
clusion of CAD, as reconfirmed by the publication
of the multicenter ACCURACY trial [16]. However,
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its use in ESRD patients is not studied due to con-
cerns about potential kidney function deterioration
in non-dialysis situations. The high calcium burden
in ESRD patients has served as the other major
barrier to use of CCTA. In diabetic patients with
chronic kidney disease, coronary calcification starts
early and progresses rapidly after initiation of he-
modialysis [17]. These and other electron beam
computed tomography (EBCT) studies have shown
accelerated coronary calcification in hemodialysis
patients [18, 19]. However, prior data comparing
EBCT calcium burden with CA has shown that cal-
cific burden in ESRD patients correlates poorly with
obstructive CAD [20]. These discrepancies could
likely be coexistent medial vascular calcification
(Monckeberg’s sclerosis or more appropriately cur-
Figure 4. C. A 56 year-old female submaximal exercise echocardiography referred for additional stress myocardial
perfusion imaging. Research CCTA shows no obstructive coronary disease.
Calcium score
Region Agatston Volume Density Threshold (1–30):
LM 0 0 Pixel Threshold: 3
RCA 0 0 Algorithm: Discrete
LAD 0 0
CX 0 0
PDA 0 0
Other 1 0 0
Other 2 0 0
Other 3 0 0
Total 0 0
Left anterior descending artery Left circumflex/obtuse marginal artery
Right coronary artery
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Figure 4. D. A 58 year-old male with ejection fraction of 40%, moderate-severe mitral regurgitation on dobutamine
echocardiography which was negative for ischemia referred for catheterization given significant mitral regurgitation.
Research CCTA in this patient shows markedly elevated calcium but no obvious obstructive coronary angiography
on CCTA confirmed by cardiac catheterization which showed minimal coronary luminal irregularities despite sub-
stantial coronary calcification.
Left anterior descending artery
Left main coronary artery Left circumflex/obtuse marginal artery
Right coronary artery
Calcium score = 4299
rently considered as American Heart Association
Stage Va and V11 lesions) that is measured as part
of the EBCT calcium assessment which cannot dif-
ferentiate intimal from medial calcification. Al-
though medial calcification contributes to overall
cardiovascular mortality in the ESRD population
[21], it is not associated with coronary atheroscle-
rosis which is more closely linked to intimal calci-
fication and adverse prognosis in both ESRD and
normal population [21]. Medial calcification can oc-
cur in younger patients who have been on dialysis
and multiple mechanisms have been proposed
[22–24].
Our study confirms prior results in ESRD pa-
tients but shows this for the first time using CCTA
as a reference rather than angiography. Although
the overall correlation between high calcific burden
and obstructive disease was good, a significant num-
ber of patients with calcium scores between 400 and
2,000  had less than 70% disease, with many hav-
ing < 50% disease by CCTA in the major coronary
arteries (Fig. 2). Furthermore, as shown in prior
trials [20, 25, 26], our study also highlights the im-
portant fact that the traditional cut-off used in the
general population for predicting higher likelihood
of obstructive CAD may not apply to the ESRD
360
Cardiology Journal 2010, Vol. 17, No. 4
www.cardiologyjournal.org
population. There was no significant overall differ-
ence between the Agatston calcium scores between
interpretable and uninterpretable segments (611.0 ±
± 1697.8 vs 648.3 ± 1354.8, p = 0.784). Further-
more, despite high mean calcium values (> 600–
–2,200), only two patients in our study population
had a major epicardial stenosis interpreted as
≥ 70%. This is consistent with the dissociation be-
tween calcium burden and obstructive CAD in
ESRD patients shown in other studies [20, 25].
Thus, widely used traditional coronary calcium cut-
off values of ≥ 400 for predicting obstructive CAD
in the general population [27] may not apply to
ESRD dialysis patients. The cut-off may be much
higher and needs to be individualized given a sub-
stantial intermix of medial and intimal calcification
contributing to higher calcium scores [13].
Although a systematic comparison between
stress testing and CCTA was not an objective of the
study, we compared the two modalities in patients
who had had a DSE as part of their RT evaluation and
the research CCTA. Almost half of DSE studies were
sub-maximal, mainly due to the inability to achieve
≥ 85% of predicted maximal heart rate. We have pre-
viously shown that sub-maximal DSE is a significant
problem in ESRD patients [6] and when being evalu-
ated for RT this poses a dilemma for clinicians who
have to consider whether an alternative test, like
nuclear perfusion stress or coronary angiography,
would be needed to conclusively rule out CAD. In the
present study, 64-slice CCTA was diagnostic in the
majority of patients with sub-maximal DSE, thus rais-
ing the possibility that it could serve as a second line
modality when further testing is contemplated.
A substantial minority (36%) of our patients had
zero calcium score. It is unclear from our study as
to why calcium was absent in this subset as no sig-
nificant differences were noted in the two groups
with and without calcium (Table 5). One factor could
be that 89% of our study population were African
Americans, where coronary calcium burden is found
to be the lowest as noted in the Multiethnic Study
of Atherosclerosis [28]. This factor, in addition to
the relatively young age in our study population, the
short duration of dialysis, and excellent control of
calcium phosphorous product, could have played
a role apart from unknown individual patient cha-
racteristics involving calcium metabolism. This as-
pect needs further research, as our study was not
designed to address this issue.
Despite the high calcium scores, only a mino-
rity of studies were considered to be of poor quali-
ty and only a very few were considered uninterpret-
able. Segments that were deemed uninterpretable
were mainly distal (accounting for 86% of uninter-
pretable segments) and related to a calcium score
≥ 400, poor signal-to-noise ratio, or an elevated
heart rate. Furthermore, there was excellent cor-
relation between the two readers for the proximal-
mid individual coronary arteries. However, there
was poor correlation between the readers in seven
of the 25 patients at the segment level, which like-
ly reflects the limitations of interpreting scans with
very high calcium scores.
Safety of CCTA
CCTA was very well tolerated in this high-risk
subset of patients. One patient developed a vasova-
gal reaction during IV access prior to the exam.
However, symptoms responded to intravenous flu-
ids and the patient was able to complete the exam-
ination. Furthermore, there were no 30 day event
rates including death, myocardial infarction, conges-
tive heart failure, or any other reactions related to
the CCTA procedure. One patient did develop
a lower GI bleed related to coumadin within 30 days
of the CCTA examination.
Limitations of the study
This is a pilot study, and therefore the results
should be verified in a larger subset of patients. The
small sample size of this study prevents definitive
conclusions. No catheterization correlation was
readily available, making true assessment of the
accuracy of the CCTA difficult as coronary cathe-
terization is still considered the gold standard tech-
nique for identifying and planning management of
CAD. About 10% of segments were deemed unin-
terpretable by both readers, although 86% of these
were in the distal vessels where revascularization
strategies likely would not be applied. However,
95% concordance was achieved at a segmental le-
vel in excluding > 50% stenosis between two read-
ers. As shown in the literature, our study suggests
that CCTA’s main strength lies in its ability to ex-
clude significant major vessel epicardial disease
which was well assessed at the patient level in
which 89% (25 of 28) of studies were deemed in-
terpretable and only 11% (3 of 28) were uninter-
pretable between both readers. Therefore, it is very
likely that once proximal to mid major epicardial
CAD is excluded, further anatomic delineation will
likely not have much impact on therapeutic strate-
gies in asymptomatic patients.
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Conclusions
CCTA seems feasible and safe as a diagnostic
screening tool to exclude major epicardial CAD in
the asymptomatic ESRD population on dialysis be-
ing evaluated for transplant. Despite high calcium
scores, current 64-slice CCTA in ESRD patients
helps to exclude major CAD, thus avoiding cardiac
catheterization. Given that more than a third of
ESRD patients may have low to zero calcium
scores, further studies are needed to correctly iden-
tify this population so that any testing could be
avoided if the patient is asymptomatic. CCTA could
also be used as the initial diagnostic strategy to
exclude significant CAD in this subset and avoid
further downstream testing in the next few years.
Our study also demonstrates that CCTA may be
a useful tool to exclude major epicardial CAD in
asymptomatic ESRD dialysis patients who have
non-diagnostic pre-operative stress tests. Further
studies in ESRD dialysis patients using CA as a re-
ference standard is needed to see if CCTA can be
useful in pre-RT ESRD patients.
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